Market Place
Sourcing Support
Generic HIV Drug Rollout To Take A Hit On Trial Push
28 Nov 2025 //
ECONOMICTIMES
Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers
07 Oct 2025 //
FIERCE PHARMA
TWN Urges Universal $40/year Access To Generic Lenacapavir
26 Sep 2025 //
PHARMABIZ
Lupin Gets Tentative FDA Nod For Biktarvy Tablets
25 Sep 2025 //
EXPRESSPHARMA
Gilead Enlists Global Fund in Access Campaign for New PrEp Med
10 Jul 2025 //
PRESS RELEASE
Emcure Pharma partners with Gilead Sciences to produce HIV drug
04 Oct 2024 //
PRESS RELEASE
Dr Reddy`s sign voluntary licenses with Gilead for HIV drug
02 Oct 2024 //
PRESS RELEASE
Gilead inks licensing deals to boost lenacapivir access
02 Oct 2024 //
FIERCE PHARMA
Merck stops testing combo drug for skin cancer as more patients discontinue
14 May 2024 //
REUTERS
US FDA mandates label updates on CAR-T cancer therapies
19 Apr 2024 //
REUTERS
Gilead aims remdesivir toward helping India outbreak; Merck pairs with 5
27 Apr 2021 //
ENDPTS
Gilead`s Truvada faces Teva generic amid switching effort
02 Oct 2020 //
FIERCE PHARMA
Mylan prices its generic remdesivir in India at $64 per 100 mg vial
06 Jul 2020 //
REUTERS
Mylan gets DGCI nod, to launch generic remdesivir at Rs 4,800 per vial
06 Jul 2020 //
BUSINESS-STANDARD
Gilead Can`t Shake New HIV Antitrust Complaint, Court Told
04 Jun 2020 //
LAW360
Beximco Pharma launches first generic remdesivir for Covid-19
22 May 2020 //
PHARMACEUTICAL-TECHNOLOGY
Cipla share price rises nearly 6% on partnership with Gilead for COVID-19
13 May 2020 //
MONEYCONTROL
AbbVie’s HCV treatment receives first for shorter treatment cycle
30 Sep 2019 //
IN-PHARMATECHNOLOGIST
Gilead’s hep C generics now own more than 20% of market
17 Sep 2019 //
FIERCE PHARMA
HHS isn`t giving up on drug prices in TV ads
22 Aug 2019 //
FIERCE PHARMA
FDA Unveils 34 New and Revised Product-Specific Draft Guidances
17 May 2019 //
RAPS
Gilead schemed with J&J, BMS to protect HIV combos: lawsuit
15 May 2019 //
FIERCE PHARMA
Tension over generic entry sees Gilead donating 2.4m bottles of PrE
15 May 2019 //
IN-PHARMATECHNOLOGIST
Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments
14 May 2019 //
CNBC
Gilead`s $3B-per-year Truvada to face generics a year early
09 May 2019 //
FIERCE PHARMA
FDA Explains Why it Waived a Shared REMS for Letairis Generics
06 May 2019 //
RAPS
Guarding a $2 billion franchise operation Gilead hustles up its sNDA for Descovy
06 Apr 2019 //
ENDPTS
Truvada (emtricitabine, tenofovir disoproxil fumarate) : Gilead vs. Zydus
15 Jan 2019 //
PATENT LITIGATION
Merck loses bid to revive $200 million Gilead verdict at U.S. high court
08 Jan 2019 //
REUTERS
Express Scripts plans `Flex` formulary focused on authorized generics
14 Nov 2018 //
BIOPHARMA DIVE
Viread® (tenofovir disoproxil fumarate) : Gilead Sciences vs. Laurus Labs
12 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Apotex
01 Nov 2018 //
PATENT LITIGATION
Gilead, Indian Generic Co. Drop Truvada Infringement Suit
10 Oct 2018 //
LAW360
Gilead, Indian Generic Co. Drop Truvada Infringement Suit
10 Oct 2018 //
LAW360
Gilead, Indian Generic Co. Drop Truvada Infringement Suit
10 Oct 2018 //
LAW360
Merck asks SCOTUS for its $200M in Gilead patent dues
26 Sep 2018 //
FIERCE PHARMA
Brazil court strips Gilead of hepatitis C drug patent
25 Sep 2018 //
REUTERS
Gilead`s subsidiary, Asegua Therapeutics to introduce Epclusa & Harvoni
25 Sep 2018 //
PHARMABIZ
Gilead to Sell Cheaper Versions of Drug That Sparked Cost Debate
25 Sep 2018 //
BLOOMBERG
Gilead to launch generic versions of its hepatitis drugs
24 Sep 2018 //
Gilead Subsidiary to Launch Epclusa and Harvoni
24 Sep 2018 //
Why This AbbVie Lawsuit Should Worry Broader Biopharma
20 Sep 2018 //
INVESTORS
FDA Issues 54 New and Revised Product-Specific Guidances
13 Sep 2018 //
RAPS
Generics group says branded drugmakers blocking $13B in annual savings
06 Sep 2018 //
BIOPHARMA DIVE
Gilead paid $510M for drug and just sold it for $3 million
24 Aug 2018 //
CNBC
Gilead loses key patent claims for Sovaldi in China
14 Aug 2018 //
ENDPTS
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead, Boehringer
08 Aug 2018 //
FIERCE PHARMA
Two pre-grant patent oppositions filed on Gilead’s Hepatitis C medicines
09 Jul 2018 //
HINDU BUSINESS LINE
Truvada® (emtricitabine/tenofovir): Gilead Sciences v. Strides Ph
27 Jun 2018 //
PATENT LITIGATION
FDA Calls Out Pharma Cos for Blocking Requests from Generic Manufacturers
18 May 2018 //
BIOSPACE
FDA ‘names and shames’ generic-blocking pharma companies
17 May 2018 //
PMLIVE
Sovaldi® (Sofosbuvir): Gilead Sciences v. Teva Pharmaceuticals USA
26 Mar 2018 //
PATENT LITIGATION
Sovaldi® (Sofosbuvir) : Gilead Sciences, v. Natco Pharma Limited
14 Mar 2018 //
PATENT LITIGATION
Gilead gets a blockbuster boost from an FDA OK of HIV triplet Biktarvy
07 Feb 2018 //
ENDPTS
Truvada® (emtricitabine & tenofovir disoproxil fumarate)elvitegravir, GS 9350 (cobicistat): ViiV Healthcare v. Gilead Sciences
07 Feb 2018 //
PATENT LITIGATION
Brain damage cases force an FDA hold on Bellicum’s lead cell therapy
31 Jan 2018 //
ENDPTS
Besieged Teva launches exclusive generic of Gilead`s Viread
15 Dec 2017 //
FIERCE PHARMA
Gilead loss of generic HIV drug battle a boost for gay community
08 Nov 2017 //
IRISHTIMES
The Medicines Patent Pool, Gilead sign licence for bictegravir
04 Oct 2017 //
PHARMABIZ
Gilead to launch injunction against Mylan & Actavis over HIV generics in Ireland
07 Jul 2017 //
PHARMAFILE
